Clinical Trial Update: Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) [Phase 1]

View source ↗

Summary

Phase 1 study of edeCesertib in participants with Cutaneous Lupus Erythematosus was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• Edecesertib (Edecesertib)

Snippet

Sponsor: Gilead Sciences | Conditions: Cutaneous Lupus Erythematosus | Phase 1 | Status: TERMINATED | Results posted: 2024-04-05